1279 related articles for article (PubMed ID: 23810785)
1. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
2. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Tasneem U; Siddiqui MT; Faryal R; Shah AA
J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Ko KS; Lee JY; Song JH; Peck KR
J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285
[TBL] [Abstract][Full Text] [Related]
7. Genotypic variability and antifungal susceptibility of Candida tropicalis isolated from patients with candiduria.
Almeida AA; Nakamura SS; Fiorini A; Grisolia AB; Svidzinski TI; Oliveira KM
Rev Iberoam Micol; 2015; 32(3):153-8. PubMed ID: 25766792
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
[TBL] [Abstract][Full Text] [Related]
9. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ
J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
12. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
15. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
[TBL] [Abstract][Full Text] [Related]
16. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
[TBL] [Abstract][Full Text] [Related]
18. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
19. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.
Kiraz N; Dag I; Oz Y; Yamac M; Kiremitci A; Kasifoglu N
J Microbiol Methods; 2010 Aug; 82(2):136-40. PubMed ID: 20493911
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
